• No results found

Use of a reamplification protocol improves sensitivity of detection of Mycobacterium tuberculosis in clinical samples by amplification of DNA

N/A
N/A
Protected

Academic year: 2020

Share "Use of a reamplification protocol improves sensitivity of detection of Mycobacterium tuberculosis in clinical samples by amplification of DNA"

Copied!
6
0
0

Loading.... (view fulltext now)

Full text

(1)

0095-1137/91/040712-06$02.00/0

Copyright © 1991,American Society forMicrobiology

Use of

a

Reamplification

Protocol

Improves Sensitivity

of

Detection

of

Mycobacterium

tuberculosis

in Clinical

Samples

by Amplification of DNA

CATHERINE PIERRE,1 DENISE LECOSSIER,1 YVES BOUSSOUGANT,2 DENIS

BOCART,1

VERONIQUE JOLY,3 PATRICKYENI,3 AND ALLAN J.

HANCE'*

InstitutNational de la Sante' etde la RechercheMedicale U.82, FacultedeMedecine Xavier

Bichat,1

and Service deMedecine Interne, Hopital Bichat-Claude Bernard,3 Paris, and Laboratoire

deMicrobiologie, HopitalLouisMourier,

Colombes,2

France Received4September 1990/Accepted 14January 1991

We have compared the sensitivity and specificity of quantitative mycobacterial culture against results obtained by usingthepolymerase chain reactionfor the detection of DNA fromorganismsof theMycobacterium tuberculosis complexin82 clinicalspecimens from patientssuspectedofhavingtuberculosis. Twoamplification protocols wereused,astandardamplification protocol, whichamplifiesa segment of thegenecodingfor the 65-kDaantigen,andaprotocolinwhich the initialamplification productsarereamplifiedwithasecond setof nested oligonucleotide primers. Althoughthe standardamplification protocolgavepositiveresults for18of18 sampleswhichgrew>100 CFU/ml andgavepositiveresults in 4 of35specimensfrompatientswithtuberculosis which were negative by culture, only 1 of 6 samples which grew <100 CFU/ml was positive. This lack of

sensitivity could not be explained by the presence of inhibitors ofTaq polymerase present in the original samples.In contrast, thereamplification protocolgavepositiveresults for 24 of 24sampleswhichwerepositive

by culture aswell as for 13 of 35 samples from patients with tuberculosis which were negative by culture

(overall sensitivity, 63%,P< 0.02, comparedwith the standardamplification protocoland routineculture). Two of 23 samplesfrompatientsnotdiagnosedashavingtuberculosisgavepositiveresults whenthestandard amplification protocol was used, but no additional false-positive resultswere seen with the reamplification protocol (overall specificity, 91%). We conclude that the use of a reamplification protocol improves the sensitivityof detection ofmycobacterialDNAinclinicalsampleswithoutsacrificing specificity. Thesensitivity of thisapproach appearstobesuperiortothat ofstandard culture techniques.

Standard techniques for the diagnosis oftuberculosis are

suboptimal. The identification of mycobacteria by micro-scopic examination is insensitive and, even when positive, doesnotpermittheidentification ofthespecies of mycobac-teria observed. Similarly, culture techniques require 3 to 6 weeks before results are available, and multiple samplesare

required to maximize the chance of obtaining a positive result(1, 2). Asaconsequence,patients suspected of having tuberculosis may be subjectedtoinvasivediagnostic

proce-dures to establish or exclude the diagnosis or may receive

possibly inappropriate empiric antituberculous therapy while awaiting results of cultures. All diagnostic tests may

ultimately be negative for some patients thought to have

tuberculosis on clinical grounds, despite extensive

evalua-tion (1, 3).

Inaneffort to overcome these limitations in the diagnosis oftuberculosis, we (5, 12) and others (4, 8, 9, 14, 17, 18, 20, 23, 24, 27) have recently developed procedures based on the

amplificationof mycobacterial DNA by use of the polymer-ase chain reaction. Preliminary studies have indicated that this procedure can be used to rapidly identify the presence of DNAfrom Mycobacterium tuberculosis in clinical samples. The diagnosis of tuberculosis is especially difficult in cases where only a few mycobacteria are present. Thus, a new

diagnostic approach which permits the detection of small

numbers of mycobacteria would be particularly useful. In

*

Correspondifng

author.

this context, thesensitivityfor the detection ofmycobacteria inclinical samples containing only small numbers of organ-isms by standard bacteriological techniques and the

sensi-tivity of detection by techniquesbased onthe amplification of

mycobacterial

DNA havebeencomparedinrelativelyfew

studies.

In this study, we have compared the sensitivity and

specificity oftwoamplification protocolsfor the detection of M. tuberculosis in clinical samples from patients suspected

ofhaving tuberculosis. Theresultsdemonstratethata stan-dard amplification protocol, which amplifies a segment of

the genecoding forthe65-kDaantigen (5, 12), could detect the presence ofmycobacterial DNAfrom organisms ofthe M. tuberculosis complex in samples containing more than 100 mycobacteria per ml but was frequently negative with samples containingfewermycobacteria. The inefficient

am-plification of mycobacterial DNA during this

amplifica-tion procedure was not due to the presence of inhibitors present in the initial sample and could be overcome by

reamplifyinganaliquot of the original amplification products

by use of a second set of nested oligonucleotide primers

recognizingDNA sequences contained within the originally

amplifiedmycobacterial DNA sequence. When this

reampli-fication protocol was used, the sensitivity for detection of M. tuberculosis was superior to that of standard culture

techniques.

(Thiswork was presented at the 30th Interscience Confer-ence on Antimicrobial Agents and Chemotherapy, Atlanta,

Ga., October 1990.)

712

on April 12, 2020 by guest

http://jcm.asm.org/

(2)

MATERIALS AND METHODS

Clinical specimens. By using standard procedures, speci-mens of sputum or gastric lavage were obtained from 32

patients admittedto Hopital Bichat-Claude Bernard (Paris) orHopital LouisMourier(Colombes)onsuspicionofhaving

pulmonary tuberculosis. Four samples were subsequently

eliminated fromthe studybecause ofatechnicalerrorduring

the extraction ofDNA. The final study group contained 70

sputum samples and 12 gastric aspirates. Samples were

decontaminated byuseof the sodium dodecyl sulfate (SDS)

method (26), neutralized, and concentrated by centrifuga-tion. An aliquot of the sample was examined for acid-fast

bacilli by usingan auramine-flurochrome stain (25), and the remainingsample was divided into twoequal portions. One

part was inoculated into Lowenstein-Jensen medium by

using quantitative culture techniques (6). The second part

was stored at

-80°C

priortoextracting DNA.

Diagnosis of tuberculosis. All patients were initially

sus-pectedof having tuberculosis either because ofthepresence

of constitutional symptoms (fever and/or weight loss) and compatible abnormalitiesonchest radiograph orbecause of

known exposure to a close family member with active

tuberculosisandrecentpositive conversion of their skintest

response to intermediate-strength purified protein deriva-tive. Nineteen of the 32 patients were ultimately diagnosed

as having tuberculosis. For the purposes ofthe study, this

diagnosiswasbasedonthe followingtwocriteria: (i) thefinal clinical diagnoses established by the primary physician in-cluded tuberculosis, and (ii) the patient was treated for

tuberculosis byuse ofastandard therapeutic protocol. The

diagnoseswereestablished without knowledge oftheresults

of the DNA amplification proceduresevaluatedin thisstudy. Oneor moreculture specimens ultimatelygrewM.

tubercu-losis in 11 of 19 patients diagnosedashaving tuberculosis.

Extraction of DNA. In most cases, DNA was extracted

fromthe frozen aliquots of theconcentratedclinical samples

as previously described (12, 16). Briefly, the specimen was

centrifuged and the precipitatewasheatedat95°Cfor 15min

in a solution of 0.1 N NaOH-2 M NaCl-0.5% SDS and centrifuged, after which the DNA was purified from the

supernatantby extraction with phenol-chloroform and

etha-nol precipitation and redissolved in 100 p.l of 10 mM Tris hydrochloride (pH 7.4) containing 0.1 mMEDTA.

In some cases, a portion of the sample was treated as

described above and the DNA was extracted from the

remaining portion by using amodification of the procedure

of Higuchi (15). In this procedure, the sample was washed once with 1 ml of phosphate-buffered saline and incubated

for 12 hat

55°C

in 0.1 ml ofamplification buffer (seebelow) containing 60 pLg of proteinase K (Sigma Chemical Co., St. Louis, Mo.) per ml, 0.45% Tween-20 (Sigma), and 0.45%

Triton X-100 (Sigma). The sample was then heated at 95°C

for 10 min.

Amplification and detection of mycobacterial DNA. The amplificationof mycobacterial DNAwas performed as pre-viously described (5, 12, 22). The final reaction mixture (50

[ld)

contained 10 mM Tris hydrochloride (pH 8.3), 50 mM KCI,2.5 mM MgCl2, 100,ugofgelatinperml,0.3 mM(each)

deoxynucleotides, 2.5 UofTaqpolymerase, 50pmoleachof the oligonucleotide primers TB-1 (5'-GAGATCGAGCTG GAGGATCC) and TB-2 (5'-AGCTGCAGCCCAAAAGGT GTT) (12), and 10 pul of sample. Samples were sequentially incubated at 95°C (1.5 min), 60°C (2 min), and 72°C (2 min extended by 4 s after each cycle) for 50 cycles with an

automated thermal cycler (The Perkin-Elmer Corp., Nor-walk, Conn.).

To reamplify mycobacterial DNA, 1 ,ul of the original

amplification products was transferred by use of a piston-type pipette (Microman;Gilson Instruments, Villiers-le-Bel,

France) to tubes containing the same reaction mixture

de-scribed above except that the oligonucleotide primers TB-1

and TB-2 were replaced by oligonucleotides TB-28 (5'-CCAT

CGATCCGAGACCCTGCTCAAGGGC) and TB-29C (5'-TG CTCTAGACTCCTCGACGGTGATGACG), which recognize

sequences contained within the mycobacterial sequence amplified by TB-1and TB-2 (12). The samples were

subse-quently amplified for an additional 50 cycles as described

above. Because the sequence of the gene coding for the

65-kDaantigen corresponding to the 3' end of TB-28differs between M. tuberculosis and most other mycobacteria, the

reamplification system favors the amplification of DNAfrom

M. tuberculosis complex organisms (data not shown). The presenceof amplified mycobacterial DNA sequences was detected as previously described (5, 12). Briefly, ali-quots ofthe amplificationproducts were electrophoresed in

2% agarose gels, the DNA was transferred to nylon

mem-branes, and the membranes were hybridized with 3 x

105

cpm

of

32P-5'-labeled

(specific activity, 1 to 3

mCi/pmol)

oligonucleotide TB-4 (12), washed, and exposed to

radio-graphic film. A sample was considered positive if a distinct signal corresponding to an amplified product ofthe appro-priate size was seen in autoradiograms exposed for 18 h.

Control samples containing no DNA were included with eachamplification procedure andwere always negative.

To test for the presence inextracts of clinical samples of

substances capable of inhibiting the amplification of DNA, a fixed amount of purified mycobacterial DNA (containing approximately 1,000 genomes) was added to 1 to 12.5,ulof

the solution obtained after extraction of clinical samples. The samples were amplified as described above, and the results were compared with those obtained for the

amplifi-cation ofmycobacterial DNA alone.

The sensitivity and specificity of the different procedures were compared by use ofaX test.

RESULTS

Detection of mycobacterial DNA by a standardamplification protocol. Fifty-nine of the 82 samplesevaluated inthis study were obtained from the 19 patientsultimately diagnosed as having tuberculosis. Culture for M. tuberculosis was posi-tive for 24 of these 59 samples; no other species of myco-bacteria were grown from these samples. The number of mycobacteria grown from positive cultures was quite vari-able, ranging from 106 to 2 CFU/ml (Fig. la).

The results for the detection of mycobacterial DNA in these samples afteramplification by ourstandard amplifica-tion protocol are shown in Fig. la. Mycobacterial DNA could be detected in 18 of 18 sampleswhichgrew more than 100CFU/ml. Acid-fast organisms were also identified in all of these samples by microscopic examination (Fig. la). In contrast, the results of the amplification procedure were negative for five of six samples which grew fewer than 100 CFU/ml, and the only sample in this group which was positiveby the amplification procedure was also positive by microscopicexamination. The amplification procedure gave positive results in4of 27 samples obtained frompatients not receivingantituberculous therapybut for which both culture and microscopic examination were negative. The overall sensitivity of the amplification procedure (39%) was not

on April 12, 2020 by guest

http://jcm.asm.org/

(3)

a

AA AA

AAA A

A ALA A A LALAL 0OO

. I

106 10 S 104 103 102 10 results of culture (CFU / ml)

b

LA AL

*sA A

A AL AL A ALAA -A-O .4

106 105 104 103 102 10

results of culture (CFU / ml)

FIG. 1. Comparison of the results ofquantitati

those obtained by the standard amplification proti

reamplification protocol (b) for thedetectionofM.t,

clinical samples from patients diagnosed as havi Samples which were positive by direct microsco (triangles) and negative bydirectexamination (cir( Solid symbols representsamples whichwere posit

amplification protocol.

significantly different from thatof culture tec

or microscopic examination (41%), but samf

few mycobacteria were likelyto benegative cation procedure.

Twenty-three of the 82 samples studied from patients diagnosed asnot havingtuberci these samples was positive by culture. T

samples did, however, give positive results cation procedure. In both cases, only one of fromtwodifferentpatientswaspositive by th procedure (overall specificity, 91%).

Detection of mycobacterial DNA by a ream

tocol. An aliquot of the original amplification reamplifiedbyuseofasetofnestedoligonuci which would specifically recognize sequen

within the amplified mycobacterial DNA

present in the spurious amplification produc

obtained by this reamplificationprotocol are

lb. All 24 samples from patients with tube

were positive by culture were positive when

cation procedure was used, including the 4 grewfewer than 100CFU/ml and whichwerc by direct microscopic examination and by amplification protocol. Furthermore, of the

3'

patients with tuberculosis which were negati

13 samples were positive by the reamplificat

Thisgroup included2 samples frompatients i mentfortuberculosis and 11 samples frompa never received antituberculous therapy. The

tivityof the reamplification procedure for the(

tuberculosis (63%) was significantly greatei

culture (41%, P < 0.02) and that of direc

examination (41%, P< 0.02).

Of the 13 samples from patients with tube werepositive by thereamplification protocolt negative by culture,5wereobtainedfrompati

othersamples evaluated in this series were p

culture and the reamplification procedure. '

0 0 0 0g

eight

samples

wereobtainedfrom fourdifferent

patients

who

o oo o o were diagnosed as havingtuberculosis despite thefact that ^

°O°OO

° noclinicalspecimen

eventually

grewM. tuberculosis. More

A0000 than one specimen was positiveby the

reamplification

pro-o Asses0

tocol in three ofthese four cases (three ofthree, two of + three, two of four, and one of two

positive

specimens,

respectively). All four ofthesepatientswerechildrenwhose mothers hadbeenrecently diagnosed as having tuberculosis no growth and who had had a recent conversion in their skin test o o000 reactivity, but none had received antituberculous

therapy

0 0000 before the time that the specimens were obtained.

A0 00 0 The two samples from

patients

diagnosed as not having A* o tuberculosis, but which were positive by the standard

am-plification

protocol,

were alsopositive after

reamplification.

]

I-

No additional samples from patients nothavingtuberculosis

were positive when the reamplification protocol was used. Thus, the overall specificityof thereamplificationprocedure

no growth was the same as that of the standard amplification protocol ive cultures and

(91%).

ocol (a) and the For all 35 of the samples which were positive when the uberculosisin59 reamplification protocol was used, a band whose molecular

tng

tuberculosis, weight corresponded to that expected for the amplification

les) are shown product ofmycobacterial DNA was visible when the

ampli-ive bythe given fication products wereelectrophoresed into 2% agarose gels and stained with ethidium bromide (Fig. 2). Furthermore, when thereamplification products were transferred tonylon

membranes and hybridized with the probe specific for M. tuberculosis, a very strongsignal was observed on autorad-:hniques (41%) iograms in all cases, evenafter an exposure time ofonly 2 h

ples

containing (Fig. 2). In contrast, when samples were amplified by the by the amplifi- standardamplification protocol, a bandcorrespondingtothe amplification product ofmycobacterial DNA was observed were obtained in 19 of 35 cases (Fig. 2), and, in some cases, the signals

ilosis. None of observed on autoradiograms, even after an 18-h exposure Iwo of the 23 period, were relatively weak.

by the amplifi- Evaluation of techniques used for preparation of samples.

three samples When aliquots of samples prepared by the alkaline

lysis

e amplification method, and which were negative when tested alone

by

the standardamplification protocol, were "spiked" withpurified

iplification pro- mycobacterial DNA, all samples gave positive results.

Fur-iproducts was thermore, the intensity of the signal observed for tubes

leotide primers containing up to 12.5

[lI

ofsample plus purified mycobacte-ices contained rial DNA were always at least 50% of that observed for

but not those samples containingthepurifiedmycobacterial DNA alone(n ts. The results = 8; data not shown).

shown in Fig. In contrast, when samples were prepared by use of a rculosis which procedure based on proteolytic digestion, and in which the

ithe reamplifi- DNA was not subsequently purified by phenol extraction

samples which and ethanol precipitation, the addition of 12.5 [L ofsample

negative both completely inhibited the amplification ofpurified

mycobac-the standard terial DNA in 9 of 13 samples, and, in 5 cases, the addition

5 samples from of as little as 1

,lI

of the sample to thepurifiedmycobacterial

ive by culture, DNA resulted in no detectable amplification of

mycobacte-:ion

procedure. rial DNA. receiving

treat-ttientswho had DISCUSSION

overall sensi- DSUSO

detection of M. We have evaluated the sensitivity and specificity of a r than that of procedure that is based on theamplification and subsequent

:t

microscopic detection ofmycobacterial DNA from organisms of the M. tuberculosis complex for the detection M. tuberculosis in rculosis which clinical specimens from patients suspected of having tuber-but which were culosis. We have found that when a standard amplification ients for whom protocol is used, the technique can detect DNA from M. ositive both by tuberculosis in samples containing >100 CFU/ml but is The remaining frequently negative for samples containing fewerorganisms.

on April 12, 2020 by guest

http://jcm.asm.org/

(4)

a

M

b

M

4

FIG. 2. Amplification of myc patients with tuberculosis (lanes culture(300, 10,2,and 60 CFU/n patientswithout tuberculosis(lan the standardamplificationprotoci

col (b), and a 7-,u aliquot of th phoresed into 2% agarose gels photographed (a and b, top). Tl nylonmembranes,and the memb] labeledoligonucleotideTB-4, wa:

diograms (a and b, bottom). Th

amplification protocol was expc reamplification protocol wasexpi the positionofmigrationexpecte ducedbytheamplificationprotoc protocol(b, 155bp).

Thus, the test was negative

negative by directexaminatioi lack ofsensitivity, which doe

presence of inhibitors of the i

samples, can bedramatically

in which the initial amplificati4

use of a set of nested oligon

sequences contained within t]

DNA amplifiedduringtheinit sensitivity of detection of M. plification protocol was used

when standard culturetechnic reamplificationprotocoldidn

test.

The lackofsensitivity ofot

be explained neither by a failure to extract mycobacterial DNA from the originalclinical material (e.g., most samples from patients with tuberculosis were shown to containM. tuberculosis DNA byusing thereamplification protocol)nor by the presence of inhibitors of Taq polymerase in the original samples. The most likely explanation is that in reactions containing low numbers of targetmolecules, non-specificamplificationproducts (e.g., amplified human DNA and primer-dimers) are generated which compete with the

2 3 4 5 6 7 mycobacterial DNA (21). This could be overcome by ream-plifying the initial amplification products with primers which recognize theinefficientlyamplifiedmycobacterialDNA but do not recognize the nonspecificamplificationproducts. This approach haspreviously beenused toincrease the sensitiv-ity ofDNA amplification for the detection of other target

sequences (7, 10, 13), and a similar approach has recently been described by Plikaytis et al. for the detection of

Mycobacterium leprae and M. tuberculosis (20).

In addition to greatly increasing the sensitivity of detec-tion of mycobacterial DNA, thereamplificationprotocol also facilitates the subsequent identification of the amplified

mycobacterial DNA. When the standard amplification pro-tocol was used,manypositive samples gave relatively weak

positive signals on autoradiograms exposed for 18 h. In contrast,when the reamplification protocol was used, aband corresponding to the amplified M. tuberculosis DNA was 2 3 4 5 6 7 visible onethidiumbromide-stained gels in all cases and all samples gave strong positive signals on autoradiograms

exposed

for as little as 2 h.

Thus,

the time

required

to

El_.".

reamplify samples

can be recovered

by

reducing

the

tirme

necessary fordetecting positivesamples. Overall,the ream-plification procedure described here requires 3 days to obtain final results. The large amount ofmycobacterial DNA present inreamplifiedsamples could alsofacilitatetheuseof

-obacterial DNA. Samples from less sensitive but more easily handled nonradioisotopic

1 to 4) which were positive by detection systems.

al,respectively) andsamples from A striking result in this study was the finding that the ies 5 to 7) were amplified by using reamplification procedure could detect the presence of M.

01(a) or thereamplification proto- tuberculosis in many clinical samples from untreated pa-le reaction products was

electro-containing ethidium bromide and

tients with

tuberculosis

which

were negative by culture.

he DNA was then transferred to Furthermore, eight such samples were obtained from four ranes were hybridized with32p-5'-

patients

for whom no clinical specimens grew mycobacteria. shed, and used to prepare autora- It is noteworthy that all of these patients were children

e autoradiogram for the standard whose mothers had active tuberculosis and who had had )sed for 18 h, and that for the recent positive conversions of their tuberculin skin tests. osed for 2 h. The arrows indicate That these patients actually had tuberculosis is strongly

d for the amplified fragment pro- supported by the finding that, in all but one case, two or :ol (a, 383 bp) and reamplification more samples from the same individual were positive when thereamplification procedure was used. Since decontamina-tion procedures are known to reduce the viability of

myco-bacteria (19), it is possible that the processing of these in all samples which were samples killed the small number of viable mycobacteria

n but positiveby culture. This present. Alternatively, someindividuals may shed

mycobac-s not appear to be due to the teria which are largely nonviable (e.g., because ofthe host Taq polymerase in the original immune response). Inthiscontext,

mycobacterial

DNA has improved by using a protocol beendetectedinculture-negativeclinical

samples

which had onproducts arereamplifiedby not been decontaminated (e.g.,

pleural

fluid and

cerebrospi-ucleotide primers recognizing nal fluid) (8, 17, 23, 27). Further studies

comparing

the he sequence of mycobacterial resultsobtained

by

culture with those basedonthe detection tial amplificationreaction. The of mycobacterial DNA should

permit

better assessment of tuberculosis when the ream- the viabilityofmycobacteria before and after

processing

for was superior to that obtained mycobacterialculture.

iueswere

used,

and theuse of

Recently,

several other groups have described systems ot reduce thespecificity ofthe basedon the

polymerase

chain reaction for the detection of mycobacteria. Most of these systems, like that described

ar

amplification protocol could here, are

specific

for DNA from

organisms

of the M.

on April 12, 2020 by guest

http://jcm.asm.org/

(5)

tuberculosis complex but cannot distinguish individual

mem-bers of this group (4, 5, 9, 14, 17, 20, 24, 27), although two systems have been described which are apparently specific

for M. tuberculosis (8, 18). When tested against purified mycobacterial DNA, several of these systems have been shown to detect as little as 1 fg of mycobacterial DNA

(equivalentto less than onemycobacterial genome) (4, 9, 18, 20, 27) and can detect the presence of fewer than 20 mycobacteria added to samples prior toextraction of DNA (4, 8, 9, 12, 20, 24). Those systems which amplify either a target sequence present in multiple copies in the M. tuber-culosis genome (8, 9, 14, 18, 27) or rRNA from M.

tubercu-losis after reverse transcription (5 x

103

copies per

myco-bacterium) (4) may prove to be more sensitive than systems based on thedetection of single copy sequences, such as the gene coding for the 65-kDa antigen used as a target in this study. In this context, Thierry et al. (27) demonstrated that a system based on the detection of the repetitive sequence IS6110 (10 to 15 copies per genome) was approximately 10-fold more sensitive than that of a system based on the

detection of the 65-kDa antigen which was similar to the standard amplification protocol used in our study. Further workis required to compare the relative sensitivities of these different systems and to determine the extent to which the useofareamplification protocol might increase their sensi-tivity.

For two different patients diagnosed as not having

tuber-culosis,oneof three samples was positive when the standard

amplification protocol was used. Because no evidence for

contamination of the reagents used for amplification were observed in this series (i.e., amplification of samples

con-tainingno DNAalways gave negative results),these

presum-ably false-positiveresults arelikely to have resulted from the

contamination of the samples duringthe extraction of DNA. Itis noteworthy,however, that the useofthereamplification protocol did not result in additionalfalse-positive results in this study. The contamination of samples might be

mini-mized by developing simpler procedures for extracting DNA. In this study, we used as starting material for the

purification ofDNAclinical samples which had been

decon-taminated forculture, thuspermitting thedirect comparison

of results obtained with the amplification procedure and standard culture techniques. A disadvantage of this

ap-proachisthat such samples have been treated with SDS. The presenceof thispotentinhibitor of Taq polymerase (11) may

explain why samples prepared by the shorter proteolytic

digestionmethod often inhibited the amplification of purified

mycobacterial DNA and necessitated the use of additional

purification steps before DNA amplification. It is possible that simpler extraction procedures may work if samples

whichhave not been decontaminated areused as astarting material andthereby diminish the risk of sample contamina-tion.

This study demonstratesthat the sensitivity of the

detec-tion of M. tuberculosis

by

use of the polymerase chain reaction is highly dependent on the techniques used to prepare the DNA for amplification and the type of

amplifi-cation protocol employed. In the reamplificationprocedure

described here, the sensitivity of the test appears to be superior to that of routine culture and this approach does not appear to adversely affect its specificity. These findings support the conclusion that this approach will prove to be useful in the rapid detection of M. tuberculosis in clinical

samples containing only small numbers of mycobacteria. It should be stressed, however, that the reamplification

proce-dure describedhere isrelatively expensive (for example, the

reagents alone necessary for amplificationcost morethan$5 persample) and labor intensive. Furthermore, this test will notobviate the need forcultures, the only establishedmeans ofdefining antibiotic susceptibility.Thus, further studiesare neededtodefine the role of this testinclinical practice.

ACKNOWLEDGMENTS

Wegratefully acknowledge thehelpofAlain LoiseauandBernard Grandchamp.

C.P. wassupported by a stipend from the Agence Nationale de RecherchessurleSIDA.

REFERENCES

1. Bates, J.H. 1979. Diagnosis of tuberculosis. Chest 76(Suppl.): 757-763.

2. Bates, J. H., P. J. Brennan, G. W. Douglas, J. C. Feeley, J. Glassroth,D.E.Kohne,W.J.Martin,L.G.Wayne, andC. R. Zeiss.1986. Improvements in thediagnosisof tuberculosis. Am. Rev.Respir. Dis.134(Suppl. 2):415-423.

3. Blair,E.B.,G. L.Brown,and A. H. Tull.1976.Computerfiles andanalyses of laboratory data from tuberculosispatients. II. Analyses of six years' data on sputum specimens. Am. Rev. Respir. Dis. 113:427-432.

4. Boddinghaus, B., T. Rogall, T. Flohr, H. Blocker, and E. C. Bottger. 1990. Detection and identification ofmycobacteriaby amplificationofrRNA. J.Clin.Microbiol. 28:1751-1759. 5. Brisson-Noel,A.,B.Gicquel,D.Lecossier,V.LUvy-Frebault,X.

Nassif,and A.J.Hance.1989.Rapid diagnosisoftuberculosisby amplificationofmycobacterialDNAinclinicalsamples.Lancet ii:1069-1071.

6. David,H. L.1976. Bacteriologyof themycobacterioses. Publi-cation no. (CDC) 76-8316. U.S. Government Printing Office, Washington, D.C.

7. Delfau,M.H.,J.P.Kerckaert,M.Collynd'Hooghe,P.Fenaux, J. L.Lai, J.P.Jouet, andB. Grandchamp. 1990. Detectionof minimal residual disease in chronicmyeloidleukemiapatients after bonemarrow transplantation by polymerase chain

reac-tion.Leukemia4:1-5.

8. DeWit, D.,L.Steyn,S.Shoemaker,andM.Sogin.1990. Direct detection ofMycobacterium tuberculosis in clinical specimens byDNAamplification. J. Clin. Microbiol. 28:2437-2441. 9. Eisenach,K.D.,M. D.Cave, J.H. Bates,andJ. T.Crawford.

1990. Polymerase chain reaction amplification ofa repetitive DNA sequence specific for Mycobacterium tuberculosis. J. Infect.Dis. 161:977-981.

10. Engelke, D. R.,P. A. Hoener, and F. S. Collins. 1988. Direct sequencingofenzymatically amplified human genomic DNA. Proc. Natl.Acad. Sci. USA85:544-548.

11. Gelfand,D. H. 1989.TaqDNApolymerase, p. 17-22. In H. A. Erlich (ed.), PCR technology. Principles and applications for DNAamplification. Stockton Press, NewYork.

12. Hance,A.J.,B.Grandchamp,V.L&vy-Fr6bault, D. Lecossier, J.

Rausier,D.Bocart,and B. Gicquel. 1989.Detection and identi-fication of mycobacteria by amplification of mycobacterial DNA. Mol. Microbiol. 3:843-849.

13. Haqqi,T.M., G.Sarkar, C.S.David, and S. S.Sommer. 1988. Specific amplification with PCR of a refractory segment of genomicDNA.Nucleic Acids Res. 16:11844.

14. Hermans, P. W. M., D. van Soolingen, J. W. Dale, A. R. J., Schuitema,R. A.McAdam,D.Catty, and J. D. A. van Embden. 1990.InsertionelementIS986 fromMycobacterium tuberculo-sis: ausefultoolfor diagnosis andepidemiology of tuberculosis. J.Clin. Microbiol. 28:2051-2058.

15. Higuchi, R. 1989.Rapid, efficient DNA extraction for PCR from cells or blood. Amplifications 2:1-3.

16. Kogan,S.C., M.Doherty, and J. Gitschier. 1987. An improved methodfor prenatal diagnosis of genetic diseases by analysis of amplifiedDNAsequences. N. Engl. J. Med. 317:985-990. 17. Pao,C.C., B. Yen, J. B. You, J. S.Maa, E. H. Fiss, and C. H.

Chang. 1990. Detection and identification of Mycobacterium tuberculosisbyDNAamplification. J. Clin. Microbiol. 28:1877-1880.

on April 12, 2020 by guest

http://jcm.asm.org/

(6)

18. Patel, R. J., J. W. U. Fries, W. F. Piessens,and D. F. Wirth.

1990. Sequenceanalysis and amplificationby polymerasechain reaction ofacloned DNAfragmentfor identificationof

Myco-bacterium tuberculosis.J. Clin. Microbiol. 28:513-518. 19. Peres, P.-J., M.-J. Gevaudan, C. Gulian, andP. de Micco.1988.

Unemethode de traitementdes produits' pathologiquesenvue

del'isolement desmycobacteries. Rev. Fr. Lab. 173:67-74. 20. Plikaytis, B. B., R. H. Gelber, and T. M. Shinnick.1990.Rapid

andsensitive detection of Mycobacterium leprae usinga

nested-primer gene amplification assay. J. Clin. Microbiol. 28:1913-1917.

21. Saiki,R. K. 1989. The design andoptimization of the PCR,p.

7-16. In H. A. Erlich (ed.), PCR technology. Principles and applications forDNAamplification. Stockton Press,NewYork. 22. Saiki, R. K., S. Scharf,F. Faloona, K. B. Muilis, G.T. Horn, H. A.Erlich, and N. Arnheim. 1985. Enzymaticamplificationof P-globin genomic sequences and restriction site analysis for diagnosis ofsicklecell anemia.Science 230:1350-1354.

23. Shankar, P., N.Manjunath,R.Lakshmi, B. Aditi, P. Seth, and Shriniwas. 1990. Identification of Mycobacterium tuberculosis bypolymerase chain reaction. Lanceti:423.

24. Sjobring, U., M. Mecklenburg, A. B. Andersen,andH.Miorner. 1990. Polymerase chain reaction for detection of Mycobacte-riumtuberculosis.J. Clin. Microbiol. 28:2200-2204.

25. Smith Wick, R. W., and H. L. David. 1971. Acridineorangeas a fluorescent counterstain with the auramine acid fast stain.

Tubercle 52:226.

26. Tacquet, A., and F. Tison. 1961. Nouvelletechniqued'isolement des mycobacteries parlelauryl-sulfate de sodium. Ann. Inst.

Pasteur(Paris) 100:676-680.

27. Thierry, D., A. Brisson-Noel, V. Vincent-LUvy-Fribault, S. Nguyen,J.-L. Guesdon,and B.Gicquel. 1990. Characterization ofa Mycobacterium tuberculosis insertion sequence, IS6110, and its application in diagnosis. J. Clin. Microbiol. 28:2668-2673.

on April 12, 2020 by guest

http://jcm.asm.org/

References

Related documents

Results: This study aims at developing and evaluating a DNA microarray-based qualitative multiplexed polymerase chain reaction (PCR) assay, Vibrant GI pathogen panel (GPP),

Three nonradioisotopic polymerase chain reaction (PCR)-based detection techniques were evaluated for sensitivity and specificity in detecting human immunodeficiency virus type 1

Detection of Mycobacterium tuberculosis in clinical samples by two- step polymerase chain reaction and nonisotopic hybridization methods. Detection and genotyping of Mycobacterium

Comparison of polymerase chain reaction, culture, and Western immunoblot serology for diagnosis of Bordetella pertussis infection.

Detection of Chlamydia trachomatis by ligase chain reaction compared with polymerase chain reaction and cell culture in urogenital specimens. COBAS AMPLICORâ„¢: a fully

Diagnosis of Pneumocystis carinii pneumonia: specificity and sensitivity of polymerase chain reaction in comparison with immunofluores- cence in bronchoalveolar lavage

The present study was conducted using ISMap02 element for nested polymerase chain reaction (nPCR) based detection of MAP in fecal samples.. The aim was to test the sensitivity

When used with the optimized reaction buffer, PrimeSTAR HS DNA Polymerase provides high fidelity, high sensitivity, and high specificity amplification for applications such as